Cart
sales@molnova.com
AI-10-47
CAS No. 1256094-31-1
AI-10-47( 1H-Benzimidazole, 2-(2-pyridinyl)-6-(trifluoromethoxy)-AI-10-47 )
Catalog No. M23426 CAS No. 1256094-31-1
AI-10-47 is a small molecule inhibitor of CBFβ-RUNX binding(IC50 : 3.2 μM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 90 | In Stock |
|
| 5MG | 93 | In Stock |
|
| 10MG | 164 | In Stock |
|
| 25MG | 307 | In Stock |
|
| 50MG | 433 | In Stock |
|
| 100MG | 607 | In Stock |
|
| 200MG | 817 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAI-10-47
-
NoteResearch use only, not for human use.
-
Brief DescriptionAI-10-47 is a small molecule inhibitor of CBFβ-RUNX binding(IC50 : 3.2 μM).
-
DescriptionAI-10-47 is a small molecule inhibitor of CBFβ-RUNX binding(IC50 : 3.2 μM).
-
In VitroAI-10-47 (10 μM) weakly inhibits CBFβ-RUNX binding.AI-10-47 significantly inhibits ME-1, TUR, M0-91, THP-1 and U937 cell growth. Western Blot Analysis Cell Line:4 × 106 SEM cells.Concentration:10 μM.Incubation Time:6 h.Result:Weakly reduced CBFβ binding to RUNX1 in cells (may due to its poor solubility).
-
In Vivo——
-
Synonyms1H-Benzimidazole, 2-(2-pyridinyl)-6-(trifluoromethoxy)-AI-10-47
-
PathwayOthers
-
TargetOther Targets
-
RecptorCBFβ-RUNX binding
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1256094-31-1
-
Formula Weight279.22
-
Molecular FormulaC13H8F3N3O
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL (358.14 mM; Need ultrasonic)
-
SMILESFC(F)(F)OC1=CC=C2N=C(C3=NC=CC=C3)NC2=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Anuradha Illendula, et al. Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers. EBioMedicine. 2016 Jun;8:117-131.
molnova catalog
related products
-
Arnicolide C
Arnicolide C exhibits significant antiallergy activity.
-
[Val3]-β-Casomorphin...
[Val3]-β-Casomorphin (1-4) amide (bovine)
-
PF-03382792
PF-03382792 (PF-3382792) is a clinical compound under phase 1 investigation for an unknown indication.
